Skip to main navigation Skip to search Skip to main content

Correction: Oncogenic KRAS confers chemoresistance by upregulating Nrf2 (Cancer Research (2014) 74 (7430-7441) DOI: 10.1158/0008-5472.CAN-14-1439)

  • Shasha Tao
  • , Shue Wang
  • , Seyed Javad Moghaddam
  • , Aikseng Ooi
  • , Eli Chapman
  • , Pak K. Wong
  • , Donna D. Zhang

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the original version of this article (1), the HMOX1 Western blot band in Fig. 1B was inadvertently duplicated from the HMOX1 Western blot band in Fig. 3B. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.

Original languageEnglish (US)
Pages (from-to)1015
Number of pages1
JournalCancer Research
Volume79
Issue number5
DOIs
StatePublished - Mar 1 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Correction: Oncogenic KRAS confers chemoresistance by upregulating Nrf2 (Cancer Research (2014) 74 (7430-7441) DOI: 10.1158/0008-5472.CAN-14-1439)'. Together they form a unique fingerprint.

Cite this